Our Leadership

Our company is led by a passionate team of professionals with deep experience in the pharmaceutical industry and a proven track record of success in developing and commercializing novel treatments for patients.

Close Button
Photo of JOHN C. JACOBS, MBA
John Jacobs is President and Chief Executive Officer of Harmony Biosciences

JOHN C. JACOBS, MBA

President and Chief Executive Officer

Read Bio
Mr. Ulrich serves as General Counsel at Harmony Biosciences

CHRISTIAN ULRICH

General Counsel

Read Bio
Jeffrey Dayno, MD is Chief Medical Officer of Harmony Biosciences

JEFFREY M. DAYNO, M.D.

Chief Medical Officer

Read Bio
Mr. Serafin is the Chief Strategy Officer at Harmony Biosciences and is responsible for leading the company’s corporate strategy, business and corporate development initiatives, and alliance management efforts, including the expansion of the company’s pipeline through the acquisition and licensing of novel rare disease therapies for patients with high, unmet needs.

ANDREW SERAFIN, JD, MBA

Chief Strategy Officer

Read Bio
Mr. Kapadia is Chief Financial Officer and has over 25 years of life sciences industry experience across multiple therapeutic areas and has provided strategic financial oversight and guidance to companies both in the United States and Europe.

SANDIP KAPADIA, CPA, MBA

Chief Financial Officer

Read Bio
Mr. Dierks is Chief Commercial Officer for Harmony Biosciences. 

JEFFREY DIERKS, MBA

Chief Commercial Officer

Read Bio
Ms. Leone is the Head of Corporate Communications for Harmony Biosciences.

NANCY LEONE

Corporate Communications

Read Bio
Mr. Bradshaw is the Head of Technical Operations at Harmony Biosciences and is responsible for leading the company’s manufacturing, chemistry and controls (CMC) development and quality assurance functions, including manufacturing and supply management strategies for the company’s commercial drug products.

DAVID BRADSHAW

Technical Operations

Read Bio
Ms. McCanless is the Head of Corporate Affairs and Public Policy and is responsible for developing and advancing Harmony’s public policy agenda with federal, regional and local governments. 

CATE MCCANLESS

Corporate Affairs and Public Policy

Read Bio
Ms. Caperelli is Head of Investor Relations for Harmony Biosciences and brings with her nearly 20 years of demonstrated experience in leading the strategy and development of comprehensive investor relations plans for publicly traded biotechnology companies.

LISA CAPERELLI

Investor Relations

Read Bio
Mr. Knouft is currently responsible for leading and ensuring strategic alignment for all market access and commercial field sales activities. 

DAVID KNOUFT

Market Access and Field Commercial

Read Bio
Ms. Glover is Chief Compliance Officer at Harmony Biosciences where she is responsible for overseeing the strategic direction and the operational excellence of Harmony’s Corporate Compliance Program.

TRICIA GLOVER

Chief Compliance Officer

Read Bio
Ms. Goldbach is the Head of Facilities Operations and Executive Administration for Harmony Biosciences.

SHARON GOLDBACH

Facilities Operations and Executive Administration

Read Bio
Ms. Murphy is the Head of Human Resources at Harmony Biosciences.

AUDREY MURPHY

Human Resources

Read Bio

Board of Directors

Jeff Aronin is chairman and chief executive officer of Paragon Biosciences

Jeff Aronin

Harmony Founder and Chairman, Paragon Chairman and CEO

Read Bio

Antonio Gracias
Managing Partner/
Chief Investment Officer
Valor Equity

Mark Graf
Private Investor
Former Chief Financial Officer
Discover Financial Services

John Jacobs
CEO
Harmony Biosciences

Jack Nielsen
Managing Director
Vivo Capital Fund VIII, L.P./
Vivo Capital Surplus Fund VIII, L.P.

Eric Motley
Executive Vice President,
Corporate Secretary
Aspen Institute

Juan Sabater
Partner
Valor Equity

Gary Sender
Former Chief Financial Officer, Nabriva plc
Independent Board Member & Consultant

Dr. Andreas Wicki
CEO
HBM Healthcare Investments (Cayman) Ltd